CN103919984A - Traditional Chinese medicine composition for treating mammary gland hyperplasia - Google Patents
Traditional Chinese medicine composition for treating mammary gland hyperplasia Download PDFInfo
- Publication number
- CN103919984A CN103919984A CN201410194846.3A CN201410194846A CN103919984A CN 103919984 A CN103919984 A CN 103919984A CN 201410194846 A CN201410194846 A CN 201410194846A CN 103919984 A CN103919984 A CN 103919984A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 67
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 210000002264 Mammary Glands, Animal Anatomy 0.000 title abstract description 8
- 210000004293 Mammary Glands, Human Anatomy 0.000 title abstract description 8
- 206010020718 Hyperplasia Diseases 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 210000000582 Semen Anatomy 0.000 claims abstract description 10
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 6
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241000545442 Radix Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 241000220262 Sinapis alba Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 244000140786 Brassica hirta Species 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 240000003743 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000000456 talus bone Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 19
- 210000000481 Breast Anatomy 0.000 description 11
- 230000003203 everyday Effects 0.000 description 10
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 210000004185 Liver Anatomy 0.000 description 5
- 210000004914 menses Anatomy 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000002522 swelling Effects 0.000 description 5
- 206010027327 Menstrual disease Diseases 0.000 description 4
- 230000002146 bilateral Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 201000000736 amenorrhea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 231100000486 side effect Toxicity 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- 208000004396 Mastitis Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N Scutellarein Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 93.8,169.3 L 64.8,165.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 90.3,162.9 L 69.9,160.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-6 atom-0' d='M 111.9,146.2 L 93.8,169.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 64.8,165.3 L 53.7,138.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 53.7,138.1 L 44.2,136.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 44.2,136.7 L 34.7,135.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-2 atom-4' d='M 53.7,138.1 L 71.8,114.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-2 atom-4' d='M 61.1,138.2 L 73.7,122.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 71.8,114.9 L 100.9,119.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 100.9,119.0 L 111.9,146.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 97.1,125.3 L 104.8,144.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 111.9,146.2 L 140.9,150.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 140.9,150.2 L 152.0,177.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 148.0,152.1 L 155.7,171.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-20 atom-7' d='M 151.1,137.2 L 146.0,143.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-20 atom-7' d='M 146.0,143.7 L 140.9,150.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 152.0,177.4 L 181.0,181.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 178.3,182.6 L 181.8,191.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 181.8,191.4 L 185.4,200.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 183.7,180.4 L 187.3,189.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 187.3,189.2 L 190.8,197.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-9 atom-11' d='M 181.0,181.5 L 199.1,158.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 199.1,158.4 L 228.1,162.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 204.2,153.2 L 224.6,156.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-19 atom-11' d='M 188.1,131.2 L 199.1,158.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 228.1,162.4 L 231.7,171.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 231.7,171.2 L 235.2,179.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-12 atom-14' d='M 228.1,162.4 L 246.2,139.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 246.2,139.3 L 255.7,140.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 255.7,140.6 L 265.2,141.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-14 atom-16' d='M 246.2,139.3 L 235.2,112.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-14 atom-16' d='M 239.1,137.4 L 231.4,118.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 235.2,112.1 L 240.3,105.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 240.3,105.6 L 245.4,99.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-16 atom-18' d='M 235.2,112.1 L 206.1,108.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 206.1,108.0 L 188.1,131.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 208.0,115.1 L 195.4,131.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 188.1,131.2 L 178.6,129.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 178.6,129.8 L 169.1,128.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='13.6' y='139.9' class='atom-3' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='21.2' y='139.9' class='atom-3' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='188.5' y='214.6' class='atom-10' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='235.6' y='195.5' class='atom-13' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='243.7' y='195.5' class='atom-13' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='271.7' y='149.2' class='atom-15' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='279.8' y='149.2' class='atom-15' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='249.7' y='94.8' class='atom-17' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='257.8' y='94.8' class='atom-17' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='155.5' y='133.0' class='atom-20' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 26.9,47.0 L 19.2,45.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 26.0,45.2 L 20.5,44.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-6 atom-0' d='M 31.8,40.8 L 26.9,47.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 19.2,45.9 L 16.2,38.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 16.2,38.6 L 13.3,38.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 13.3,38.2 L 10.4,37.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-2 atom-4' d='M 16.2,38.6 L 21.0,32.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-2 atom-4' d='M 18.2,38.6 L 21.6,34.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 21.0,32.4 L 28.8,33.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 28.8,33.5 L 31.8,40.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 27.8,35.1 L 29.9,40.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 31.8,40.8 L 39.6,41.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 39.6,41.8 L 42.5,49.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 41.5,42.3 L 43.5,47.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-20 atom-7' d='M 42.4,38.2 L 41.0,40.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-20 atom-7' d='M 41.0,40.0 L 39.6,41.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 42.5,49.1 L 50.3,50.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 49.6,50.5 L 50.6,53.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 50.6,53.2 L 51.7,55.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 51.0,49.9 L 52.1,52.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 52.1,52.6 L 53.2,55.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-9 atom-11' d='M 50.3,50.2 L 55.1,44.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 55.1,44.0 L 62.9,45.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 56.5,42.6 L 62.0,43.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-19 atom-11' d='M 52.2,36.7 L 55.1,44.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 62.9,45.1 L 64.0,47.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 64.0,47.8 L 65.1,50.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-12 atom-14' d='M 62.9,45.1 L 67.8,38.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 67.8,38.9 L 70.7,39.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 70.7,39.3 L 73.6,39.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-14 atom-16' d='M 67.8,38.9 L 64.8,31.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-14 atom-16' d='M 65.9,38.4 L 63.8,33.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 64.8,31.6 L 66.2,29.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 66.2,29.8 L 67.7,28.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-16 atom-18' d='M 64.8,31.6 L 57.0,30.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 57.0,30.5 L 52.2,36.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 57.5,32.4 L 54.2,36.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 52.2,36.7 L 49.3,36.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 49.3,36.3 L 46.4,35.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='2.8' y='40.5' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='6.6' y='40.5' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='51.5' y='60.5' class='atom-10' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='64.1' y='55.4' class='atom-13' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='68.2' y='55.4' class='atom-13' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='73.8' y='43.0' class='atom-15' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='77.9' y='43.0' class='atom-15' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='67.8' y='28.4' class='atom-17' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='72.0' y='28.4' class='atom-17' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='42.6' y='38.6' class='atom-20' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NS4wJyBoZWlnaHQ9Jzg1LjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gMjIuNyw1MS4wIEwgMTEuMSw1My4zJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gMjAuNSw0OS4wIEwgMTIuNCw1MC42JyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0xMyBhdG9tLTAgYXRvbS01JyBkPSdNIDIyLjcsNTEuMCBMIDI2LjUsMzkuOCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMSBhdG9tLTEgYXRvbS0yJyBkPSdNIDExLjEsNTMuMyBMIDMuNCw0NC40JyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0yIGF0b20tMiBhdG9tLTMnIGQ9J00gMy40LDQ0LjQgTCA3LjIsMzMuMicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMiBhdG9tLTIgYXRvbS0zJyBkPSdNIDYuMiw0My41IEwgOC44LDM1LjcnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTMgYXRvbS0zIGF0b20tNCcgZD0nTSA3LjIsMzMuMiBMIDE4LjgsMzAuOScgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNCBhdG9tLTQgYXRvbS01JyBkPSdNIDE4LjgsMzAuOSBMIDI2LjUsMzkuOCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNCBhdG9tLTQgYXRvbS01JyBkPSdNIDE4LjIsMzMuOCBMIDIzLjYsNDAuMCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNSBhdG9tLTUgYXRvbS02JyBkPSdNIDI2LjUsMzkuOCBMIDM4LjEsMzcuNicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNiBhdG9tLTYgYXRvbS03JyBkPSdNIDM4LjEsMzcuNiBMIDQ1LjksNDYuNCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNiBhdG9tLTYgYXRvbS03JyBkPSdNIDM3LjUsNDAuNCBMIDQyLjksNDYuNycgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNyBhdG9tLTcgYXRvbS04JyBkPSdNIDQ1LjksNDYuNCBMIDU3LjUsNDQuMicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtOCBhdG9tLTggYXRvbS05JyBkPSdNIDU3LjUsNDQuMiBMIDY1LjIsNTMuMScgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtOCBhdG9tLTggYXRvbS05JyBkPSdNIDYwLjQsNDQuMCBMIDY1LjgsNTAuMicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTQgYXRvbS0xMyBhdG9tLTgnIGQ9J00gNjEuMywzMy4wIEwgNTcuNSw0NC4yJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC05IGF0b20tOSBhdG9tLTEwJyBkPSdNIDY1LjIsNTMuMSBMIDc2LjgsNTAuOCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTAgYXRvbS0xMCBhdG9tLTExJyBkPSdNIDc2LjgsNTAuOCBMIDgwLjYsMzkuNicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTAgYXRvbS0xMCBhdG9tLTExJyBkPSdNIDc1LjIsNDguMyBMIDc3LjgsNDAuNScgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTEgYXRvbS0xMSBhdG9tLTEyJyBkPSdNIDgwLjYsMzkuNiBMIDcyLjksMzAuNycgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTIgYXRvbS0xMiBhdG9tLTEzJyBkPSdNIDcyLjksMzAuNyBMIDYxLjMsMzMuMCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMTIgYXRvbS0xMiBhdG9tLTEzJyBkPSdNIDcxLjYsMzMuNCBMIDYzLjUsMzUuMCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPC9zdmc+Cg== C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 230000003419 expectorant Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003902 lesions Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 230000002588 toxic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000269 Abscess Diseases 0.000 description 1
- 206010063928 Amenorrhoea-galactorrhoea syndrome Diseases 0.000 description 1
- 241001105170 Angelica anomala Species 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 240000003472 Citrus aurantium Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 210000000981 Epithelium Anatomy 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 208000001365 Hyperprolactinemia Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010039083 Rhinitis Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000002435 Tendons Anatomy 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 235000004877 Vaccaria hispanica subsp hispanica Nutrition 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229930013930 alkaloids Natural products 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001605 fetal Effects 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000021268 hot food Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
The invention relates to the technical field of traditional Chinese medicine, and aims to provide a traditional Chinese medicine composition for treating mammary gland hyperplasia according to understanding mechanism on mammary gland hyperplasia of the traditional Chinese medicine. The composition is prepared from traditional Chinese medicine raw materials with the following weight ratio: 13 parts to 17 parts of salvia miltiorrhiza, 13 parts to 17 parts of astragalus, 13 parts to 17 parts of codonopsis pilosula, 13 parts to 17 parts of semen vaccariae, 8 parts to 12 parts of chinese thorowax roots, 8 parts to 12 parts of fructus aurantii, 8 parts to 12 parts of angelica dahurica, 8 parts to 12 parts of rhizoma cyperi, 8 parts to 10 parts of Chinese angelicas, 8 parts to 10 parts of thunberg fritillary bulbs and 8 parts to 10 parts of white mustard seed. By means of the traditional Chinese medicine composition for treating the mammary gland hyperplasia, raw materials can be gotten easily, the curative effect is good, and traditional Chinese medicine composition has no side effects and has been used by hundreds of mammary gland hyperplasia patients, and the statistics show that the effective rate reaches above 93 %.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically refer to a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy refers to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of carrying out property connective tissue, and its pathogenic factor is mainly due to endocrine hormone imbalance.Cyclomastopathy is the modal cystic hyperplasia of breast of women, should prevent in advance.
at present treatment take Drug therapy and therapeutic method of surgery more,cystic hyperplasia is chronic disease, and endocrine disturbance is serious, and pathological tissues is poor to the sensitivity of medicine, and cryptomere lump disappears slow, and treatment time is long, sometimes needs western drug for oral administration just onset in six months to a year.
while utilizing operation, can generally adopt Operative total removal art,this is the Therapeutic Method that only has local patholoic change person best, and as long as, by local bulk lesion resection, multipotency is received certainty therapeutic effect.If existing obvious canceration trend, or be diagnosed as precancerous lesion through biopsy, should go simple newborn excision, to ensure safety.In addition, when galactorrhea appears in patient, be also noted that with hyperprolactinemia or amenorrhea galactorrhea syndrome difference and come, in case mistaken diagnosis.
But the medicine of doctor trained in Western medicine has certain side effect, can not be completely cured, operative treatment also has a lot of side effect.
Summary of the invention
The object of the invention is the understanding mechanism to cyclomastopathy one disease according to the traditional Chinese medical science, a kind of Chinese medicine composition for the treatment of cyclomastopathy is provided, be free from side effects, cyclomastopathy does not recur substantially.
The technical solution used in the present invention is: a kind of Chinese medicine composition for the treatment of cyclomastopathy, it is that raw material Chinese medicine composition by following weight portion proportioning forms: Radix Salviae Miltiorrhizae 13-17 part Radix Astragali 13-17 part Radix Codonopsis 13-17 part Semen Vaccariae 13-17 part Radix Bupleuri 8-12 part Fructus Aurantii 8-12 part Radix Angelicae Dahuricae 8-12 part Rhizoma Cyperi 8-12 part Radix Angelicae Sinensis 8-10 part Bulbus Fritillariae Thunbergii 8-10 part Semen Sinapis Albae 8-10 part.
Treat a Chinese medicine composition for cyclomastopathy, it is that raw material Chinese medicine composition by following preferential weight portion proportioning forms: 9 parts of 9 parts of Semen Sinapis Albaes of 9 parts of Bulbus Fritillariae Thunbergiis of 10 parts of Radix Angelicae Sinensis of 10 portions of Rhizoma Cyperis of 10 parts of Radixs Angelicae Dahuricae of 10 parts of Fructus Aurantiis of 15 parts of Radix Bupleuri of 15 parts of Semen Vaccariae of 15 parts of Radix Codonopsis of 15 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
The instructions of taking of Chinese medicine composition provided by the present invention is: after the raw material Chinese medicine of above-mentioned weight portion proportioning is mixed, according to the method for the fried Chinese medicine of tradition, every pair is got its medicine juice 100ml, sooner or later take for twice, and within 30th, be a course for the treatment of.
Each raw material Chinese medicine in above-mentioned Chinese medicine composition is all on the books in Chinese medicine voluminous dictionary.
Radix Salviae Miltiorrhizae has another name called Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae, Arisaema balansae Engl. etc.For dicotyledon Labiatae, dry root and rhizome.Main product in Anhui, the ground such as Henan, Shaanxi.Radix Salviae Miltiorrhizae is Labiatae salvia, and its root is a kind of Chinese medicine, perennial herb, and root is used as medicine, containing TANSHINONES, for robustness emmenagogue, there are blood stasis dispelling, tissue regeneration promoting, invigorate blood circulation, the effectiveness such as regulating menstruation, be gynecological's key medicine, cure mainly metrorrhagia, menoxenia, blood stasis, stomachache, dysmenorrhoea, amenorrhea, mausoleum pain.
The Radix Astragali, has another name called continuous stilbene, year SHENGCAO this, main root is plump, wooden, normal branch, canescence,, it has enhancing human body immunity function, protects the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Radix Codonopsis is the conventional traditional tonic of China, has invigorating the spleen and replenishing QI, the effect of spleen invigorating lung benefiting.Modern study, Radix Codonopsis is containing various saccharides, phenols, sterol, volatile oil, scutellarein glucosid, Saponin and Alkaloid, there is enhancing immunity, blood vessel dilating, blood pressure lowering, improve microcirculation, strengthen the effects such as hemopoietic function, the outer leukopenia that chemotherapy radiotherapy is caused has castering action, the stagnation of QI, liver-fire Sheng person forbidding; Evil Sheng and just not empty person should not use.
Semen Vaccariae is the ripe dry seed of pinkwort Vaccaria segetalis, annual or biennial herb
,seed is used as medicine; Hardship, flat.Return liver, kidney channel; Promoting blood circulation to restore menstrual flow, stimulating milk secretion detumescence, inducing diuresis for treating stranguria syndrome, for agalactia, amenorrhea, dysmenorrhea, acute mastitis swells and ache.
Radix Bupleuri, belongs to shrub, perennial herb, 70 centimetres of general high 40 –, are the Chinese medicine of clearind deficient heat, for cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus come off, menoxenia.
Fructus Aurantii: source: this product is the dry immature fruit of rutaceae Citrus aurantium Linn. and variety thereof, gather when peel is still green July, is two halves from middle part crosscut, dries or cold drying effect and effect dispelling the stagnated QI, row expectorant, removing food stagnancy.Control chest and diaphragm expectorant stagnant, the feeling of stuffiness in chest, coerce swollen, food stagnation, eructation, vomiting, heavy after dysentery, proctoptosis, uterine prolapse.
The Radix Angelicae Dahuricae is the samphire Xingan Radix Angelicae Dahuricae (praying the Radix Angelicae Dahuricae), storehouse and the Radix Angelicae Dahuricae (angelica anomala) and Radix angelicae dahuricae (Radix Angelicae Dahuricae (Radix Heraclei Scabridi)), with root, be used as medicine, the functions such as dehumidifying, evacuation of pus granulation promoting, promoting blood circulation and stopping pain that get rid of illness, cure mainly anemofrigid cold, headache, rhinitis, toothache, the diseases such as leucorrhea with red and white discharge, pain furuncle and phyma poison, also can make spice, there is cultivation some provinces and regions in the north, market one's own products more, and minority is adjusted outside the province.Generally be born in by sylvan life, border, small stream, shrubbery and meadow, mountain valley.
Rhizoma Cyperi has another name called Rhizoma Cyperi, original name " dried tuber ", < < Mingyi Bielu > > begins to be loaded in, classify middle product as, < < Tang materia medica > > begins to claim Rhizoma Cyperi.< < Compendium of Materia Medica > > lists careless portion fragrant grass class in, name " dried tuber Rhizoma Cyperi ", and the pungent micro-hardship of nature and flavor is sweet, flat.Function cures mainly the resolving depression of regulating the flow of vital energy; Menstruction regulating and pain relieving; Antiabortive.Main distending pain over the hypochondrium; Mammary swelling is educated; Hernia pain; Menoxenia; Gastral cavity abdomen feeling of fullness pain; Belch acid regurgitation, vomiting and nausea; Abdominal pain during menstruation; Bleeding not during menses; Frequent fetal movement.For stagnation of QI due to depression of the liver, breast, the side of body, abdominal distention, dyspepsia, breast gastral cavity painful abdominal mass is vexed, colic of cold type stomachache, distending pain of the breast, menoxenia, amenorrhea dysmenorrhea.
Radix Angelicae Sinensis, call dryly return, horse hair Radix Angelicae Sinensis, the Qin which, horse hair are returned, cloud is returned, western Radix Angelicae Sinensis, Min Radix Angelicae Sinensis, Radix Angelicae Sinensis, Radix Angelicae Sinensis body, contain Radix Angelicae Sinensis, Radix Angelicae Gigatis herbaceos perennial, at distribution in China in Gansu, the ground such as Yunnan, Sichuan, Qinghai, Shaanxi, Hunan, Hubei, Guizhou, all there is cultivation various places, the root of Radix Angelicae Sinensis can be used as medicine, and is one of the most frequently used Chinese medicine.
Bulbus Fritillariae Thunbergii, perennial herb, bulb hemispherical, leaf stockless; The leaf of the lower portion of the stem is to life, rare alternate, and narrow lanceolar is to linear, rare alternate, blade is shorter, tip tendril.Function cures mainly removing heat-phlegm, and powder detoxifcation is controlled cough due to pathogenic wind-heat, lung abscess sore throat, scrofula, sore swollen toxin.
Semen Sinapis Albae, another name hot food, the dry mature seed of a year or biennial plant Caulis et Folium Sinapis albee, Cruciferae, spherical in shape, surperficial canescence is to faint yellow, plants skin thin and crisp, has oiliness.Odorless, acrid in the mouth is peppery, can be used as medicine, and mainly originates from the ground such as Anhui, Henan, Sichuan, Shandong.In all parts of the country have cultivation, [nature and flavor] odorless, acrid in the mouth, peppery, [function]: warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral pain relieving, [curing mainly]: reduce phlegm by drink more; Mass dissipating and swelling eliminating.Main cough with asthma abundant expectoration; Fullness in the chest and hypochondriac pain; Numb limbs and tense tendons; Arthralgia; Multiple abscess caused by damp-phlegm; Carbuncle of yin nature toxic swelling.Control acute mastitis, breast carcinoma, mammary gland pain, tuberculosis, phlegm retention cough with asthma, fullness and distention in the chest and hypochondrium pain, regurgitation vomiting, aphasia due to apoplexy, limbs arthralgia pain is numb, beriberi, carbuncle of yin nature, toxic swelling, treating swelling and pain by traumatic injury.
Pharmacology of the present invention is thought: cyclomastopathy one disease, Radix Bupleuri, Rhizoma Cyperi, Fructus Aurantii all enter Liver Channel, soothing liver-QI for relieving depression, the Radix Astragali, Radix Codonopsis, Radix Angelicae Sinensis share, replenishing QI to invigorate the spleen, Semen Vaccariae is the newborn network of dredging, Bulbus Fritillariae Thunbergii, Semen Sinapis Albae, Radix Angelicae Dahuricae heat clearing away eliminating stagnation, each raw material herbal medicine efficacy in Chinese medicine composition provided by the present invention is played altogether, blood circulation promoting and blood stasis dispelling, repercussive eliminating stagnation, has good curative effect to cyclomastopathy one disease.
The present invention has no side effect, good drug efficacy.
The specific embodiment
Below in conjunction with embodiment, the present invention is described in further details, but is not limitation of the present invention.
Embodiment 1: a kind of Chinese medicine composition for the treatment of cyclomastopathy, it is that raw material Chinese medicine composition by following weight proportion forms: 8 parts of 8 parts of Semen Sinapis Albaes of 8 parts of Bulbus Fritillariae Thunbergiis of 8 parts of Radix Angelicae Sinensis of 8 portions of Rhizoma Cyperis of 8 parts of Radixs Angelicae Dahuricae of 8 parts of Fructus Aurantiis of 13 parts of Radix Bupleuri of 13 parts of Semen Vaccariae of 13 parts of Radix Codonopsis of 13 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
2 one kinds of Chinese medicine compositions for the treatment of cyclomastopathy of embodiment, it is that raw material Chinese medicine composition by following weight proportion forms: 10 parts of 10 parts of Semen Sinapis Albaes of 10 parts of Bulbus Fritillariae Thunbergiis of 12 parts of Radix Angelicae Sinensis of 12 portions of Rhizoma Cyperis of 12 parts of Radixs Angelicae Dahuricae of 12 parts of Fructus Aurantiis of 17 parts of Radix Bupleuri of 17 parts of Semen Vaccariae of 17 parts of Radix Codonopsis of 17 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
3 one kinds of Chinese medicine compositions for the treatment of cyclomastopathy of embodiment, it is that raw material Chinese medicine composition by following weight proportion forms: 9 parts of 9 parts of Semen Sinapis Albaes of 9 parts of Bulbus Fritillariae Thunbergiis of 10 parts of Radix Angelicae Sinensis of 10 portions of Rhizoma Cyperis of 10 parts of Radixs Angelicae Dahuricae of 10 parts of Fructus Aurantiis of 15 parts of Radix Bupleuri of 15 parts of Semen Vaccariae of 15 parts of Radix Codonopsis of 15 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
Embodiment 4: below in conjunction with case, effect of the present invention is described in further details.
Case 1 Liu, female, 43 years old, before taking medicine, suffer from cyclomastopathy, bilateral breast carrys out premenstrual severe pain, takes every day after medicine of the present invention, takes 1 pair of medicine every day, takes medicine after 30 pairs, and cyclomastopathy symptom disappears completely, and physical recovery is normal.
Case 2 Lee so-and-so, female, 39 years old, before taking medicine, suffer from cyclomastopathy, premenstrual left side mammary gland is serious, and right breast is swollen, during menstruation, accompany the serious distending pain of lower abdomen,, take every day after medicine of the present invention, take 1 pair of medicine every day, take medicine after 35 pairs, cyclomastopathy disappears completely, and dysmenorrhea symptom disappears completely, and physical recovery is normal.
Case 3 weeks certain, female, 35 years old, before taking medicine, suffer from cyclomastopathy, bilateral distending pain of the breast, takes after medicine of the present invention every day, takes 1 pair of medicine every day, takes medicine after 45 pairs, cyclomastopathy disappears completely, dysmenorrhea symptom disappears completely, physical recovery is normal.
Case 4 is thanked so-and-so, female, and 30 years old, before taking medicine, suffer from cyclomastopathy, irregular menses, bilateral distending pain of the breast, takes after medicine of the present invention every day, takes 1 pair of medicine every day, takes medicine after 35 pairs, and cyclomastopathy disappears completely, and dysmenorrhea symptom disappears completely, and physical recovery is normal.
Case 5 Chens, female, 36 years old, suffers from cyclomastopathy before taking medicine, the serious distending pain of bilateral breast, menstrual cycle is inaccurate, through fore udder distending pain more, takes every day after medicine of the present invention, takes 1 pair of medicine every day, take medicine after 45 pairs, cyclomastopathy disappears completely, and dysmenorrhea symptom disappears completely, and physical recovery is normal.
Claims (2)
1. a Chinese medicine composition for the treatment of cyclomastopathy, it is characterized in that, it is that raw material Chinese medicine composition by following weight portion proportioning forms: Radix Salviae Miltiorrhizae 13-17 part Radix Astragali 13-17 part Radix Codonopsis 13-17 part Semen Vaccariae 13-17 part Radix Bupleuri 8-12 part Fructus Aurantii 8-12 part Radix Angelicae Dahuricae 8-12 part Rhizoma Cyperi 8-12 part Radix Angelicae Sinensis 8-10 part Bulbus Fritillariae Thunbergii 8-10 part Semen Sinapis Albae 8-10 part.
2. a Chinese medicine composition for the treatment of cyclomastopathy, it is characterized in that, it is that raw material Chinese medicine composition by following preferential weight portion proportioning forms: 9 parts of 9 parts of Semen Sinapis Albaes of 9 parts of Bulbus Fritillariae Thunbergiis of 10 parts of Radix Angelicae Sinensis of 10 portions of Rhizoma Cyperis of 10 parts of Radixs Angelicae Dahuricae of 10 parts of Fructus Aurantiis of 15 parts of Radix Bupleuri of 15 parts of Semen Vaccariae of 15 parts of Radix Codonopsis of 15 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410194846.3A CN103919984A (en) | 2014-05-10 | 2014-05-10 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410194846.3A CN103919984A (en) | 2014-05-10 | 2014-05-10 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103919984A true CN103919984A (en) | 2014-07-16 |
Family
ID=51138526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410194846.3A Pending CN103919984A (en) | 2014-05-10 | 2014-05-10 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103919984A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815148A (en) * | 2015-04-27 | 2015-08-05 | 吴联合 | Pharmaceutical composition for treating hyperplasia of mammary glands |
| CN105920084A (en) * | 2016-06-07 | 2016-09-07 | 宋佳玉 | Traditional Chinese medicine composition for treating breast cancer and preparation method of traditional Chinese medicine composition |
| CN106138664A (en) * | 2015-04-08 | 2016-11-23 | 陈伯顺 | A kind of medicine treating cyclomastopathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416849A (en) * | 2001-11-05 | 2003-05-14 | 张高军 | Externally applied medicine for treating mastopathy and its prepn |
| CN103751702A (en) * | 2013-12-12 | 2014-04-30 | 王芬 | Breast cancer treatment traditional Chinese medicine |
-
2014
- 2014-05-10 CN CN201410194846.3A patent/CN103919984A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416849A (en) * | 2001-11-05 | 2003-05-14 | 张高军 | Externally applied medicine for treating mastopathy and its prepn |
| CN103751702A (en) * | 2013-12-12 | 2014-04-30 | 王芬 | Breast cancer treatment traditional Chinese medicine |
Non-Patent Citations (1)
| Title |
|---|
| 吴国春: "《自拟解郁散结汤治疗乳腺增生病例临床观察》", 《黑龙江中医药》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106138664A (en) * | 2015-04-08 | 2016-11-23 | 陈伯顺 | A kind of medicine treating cyclomastopathy |
| CN104815148A (en) * | 2015-04-27 | 2015-08-05 | 吴联合 | Pharmaceutical composition for treating hyperplasia of mammary glands |
| CN104815148B (en) * | 2015-04-27 | 2018-08-21 | 吴联合 | A kind of pharmaceutical composition for treating the proliferation of mammary gland |
| CN105920084A (en) * | 2016-06-07 | 2016-09-07 | 宋佳玉 | Traditional Chinese medicine composition for treating breast cancer and preparation method of traditional Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20130053653A (en) | A method for manufacturing the composition for treating wemen's disease | |
| CN101371914A (en) | Chinese medicine health-care brassiere | |
| CN104826033A (en) | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof | |
| CN103919984A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| KR20190110229A (en) | A composition containing natural materials extract as an active ingredient for treatment of menopause symptoms, and manufacturing method of the same | |
| CN104997882A (en) | Traditional Chinese medicine for treating adenomyosis | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN103908633A (en) | Chinese herbal preparation for treating ovarian cyst | |
| CN104758524A (en) | Traditional Chinese medicinal composition for treating hepatic hemangioma with symptoms of phlegm dampness and retention | |
| CN108653632A (en) | It is a kind of to be used to treat Chinese medicine preparation of mammary gland disease and preparation method thereof | |
| CN104189234A (en) | Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis | |
| CN103463449A (en) | Traditional Chinese medicine composite used for treating haemorrhoids and preparation method and application thereof | |
| CN103893521A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN105535243A (en) | Medicine for treating intractable constipation | |
| CN107952036B (en) | Traditional Chinese medicine preparation for reducing blood sugar and preparation method thereof | |
| CN104083710A (en) | Traditional Chinese medicine preparation for treating scleroderma | |
| CN110575466A (en) | Composition for increasing bone mineral density and application thereof | |
| CN102861204A (en) | Medicine for preventing and treating postpartum diseases of ruminants and preparation method thereof | |
| CN108186785A (en) | A kind of 12 taste Chinese medicine compositions for treating chronic pelvic inflammatory disease and its application | |
| CN106071141A (en) | A kind of down producing goat feed additive | |
| CN108714167B (en) | A Chinese medicinal preparation for external use for treating vitiligo, and its preparation method | |
| CN105148167A (en) | Traditional Chinese medicine composition for treating dysmenorrheal with syndrome of stagnation and congelation of cold-damp | |
| CN108704040B (en) | Traditional Chinese medicine composition and application thereof | |
| CN105267687A (en) | Traditional Chinese medicine preparation for treating acute tonsillitis and preparation method thereof | |
| CN108066731B (en) | Chinese herbal medicine composition for treating Barrett esophagus and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140716 |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) |